Ensysce Biosciences, Inc. (ENSCW)

OTCMKTS · Delayed Price · Currency is USD · Warrants
0.0250
+0.0034 (15.47%)
At close: Jul 9, 2025
20.77%
Market Cap 3.78M
Revenue (ttm) 6.22M
Net Income (ttm) -6.82M
Shares Out n/a
EPS (ttm) -7.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 371,000
Average Volume 28,357
Open 0.0220
Previous Close 0.0217
Day's Range 0.0142 - 0.0264
52-Week Range 0.0033 - 0.0390
Beta n/a
RSI 61.99
Earnings Date Aug 11, 2025

About Ensysce Biosciences

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company’s lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2003
Employees 8
Stock Exchange OTCMKTS
Ticker Symbol ENSCW
Full Company Profile

News

There is no news available yet.